Porton Biologics Announces Closing Series-A Financing to Drive Commercial Production of Gene and Cell Therapy

SUZHOU, China, April 19, 2021 /PRNewswire/ -- On April 16, 2021, Suzhou Porton Biologics Ltd. (hereinafter referred to as Porton Biologics), a subsidiary of Porton Pharma Solutions Ltd. (hereinafter referred to as...

Full "IntellAsia: Resources" article